{
    "Trade/Device Name(s)": [
        "G5 Infinity Blood Glucose Monitoring System",
        "G5 Infinity Meter",
        "G5 Infinity Test Strips",
        "Infinity Blood Glucose Monitoring System",
        "Infinity Meter",
        "Infinity Test Strips"
    ],
    "Submitter Information": "US Diagnostics, Inc.",
    "510(k) Number": "K082201",
    "Predicate Device Reference 510(k) Number(s)": [
        "K024194",
        "K984261",
        "K021513"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "CGA",
        "JJX"
    ],
    "Summary Letter Date": "February 9, 2009",
    "Summary Letter Received Date": "February 10, 2009",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Blood Glucose Test System, Glucose Oxidase"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Infinity Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical detection"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "System",
        "Meter",
        "Test Strips"
    ],
    "Document Summary": "FDA 510(k) summary for G5 Infinity Blood Glucose Monitoring System using electrochemical technology for glucose measurement in whole blood",
    "Indications for Use Summary": "For quantitative measurement of glucose in whole blood as an aid in monitoring diabetes management in home and clinical settings; for in vitro diagnostic use with testing sites including fingertip and alternate locations; not for screening or diagnosis of diabetes or use with neonates",
    "fda_folder": "Clinical Chemistry"
}